TEXT-EXTRACT 2 filename2.txt April 10, 2020 Mark Dybul Executive Vice Chair Enochian Biosciences Inc 2080 Century Park East, Suite 906 Los Angeles, CA 90067 Re: Enochian Biosciences Inc Form 10-K for the fiscal year ended June 30, 2019 Filed September 30, 2019 File No. 001-38758 Dear Mr. Dybul: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences